教育中心 >> 预读材料
-
Causes, Timing, and Impact of Dual Antiplatelet Therapy Interruption for Surgery (from the Patterns of Non-adherence to Anti-platelet Regimens In Stented Patients Registry)JOURNAL：Am J Cardiol.
-
Clinical epidemiology of heart failure with preserved ejection fraction (HFpEF) in comparatively young hospitalized patientsJOURNAL：Int J Cardiol.
-
Seattle Heart Failure and Proportional Risk Models Predict Benefit From Implantable Cardioverter-DefibrillatorsJOURNAL：J Am Coll Cardiol.
-
Safety of six-month dual antiplatelet therapy after second-generation drug-eluting stent implantation: OPTIMA-C Randomised Clinical Trial and OCT SubstudyJOURNAL：EuroIntervention.
-
Early Rhythm-Control Therapy in Patients with Atrial FibrillationJOURNAL：N Engl J Med.
-
The spectrum of heart failure: value of left ventricular ejection fraction and its moving trajectoriesJOURNAL：Eur Heart J.
-
Positive recommendation for angiotensin receptor/neprilysin inhibitor: First medication approval for heart failure without "reduced ejection fraction"JOURNAL：Can J Cardiol.
-
Ranolazine in High-Risk Patients With Implanted Cardioverter-Defibrillators - The RAID TrialJOURNAL：J Am Coll Cardiol.
-
Fractional flow reserve derived from computed tomography coronary angiography in the assessment and management of stable chest pain: the FORECAST randomized trialJOURNAL：Eur Heart J.
-
Fractional Flow Reserve-Guided Complete Revascularization Improves the Prognosis in Patients With ST-Segment-Elevation Myocardial Infarction and Severe Nonculprit Disease: A DANAMI 3-PRIMULTI Substudy (Primary PCI in Patients With ST-Elevation Myocardial Infarction and Multivessel Disease: Treatment of Culprit Lesion Only or Complete Revascularization)JOURNAL：Circ Cardiovasc Interv.
http://www.cbsmd.cn Contact us by cbs@cbsmd.cn
Copyright ⓒ CBSMD Nanjing China. All rights reserved.
